Inspire Medical Systems — Third Quarter 2026 Earnings Summary

Inspire Medical Systems reported third-quarter 2026 revenue of $206.7 million, a 7.9% decrease from the prior year period driven by U.S. coding and reimbursement challenges. The company recorded a net loss of $24.4 million, or $0.84 per diluted share, while adjusted net earnings were $4.1 million, or $0.14 per diluted share. Operating expenses rose to $206.6 million, primarily due to $24.1 million in restructuring charges and $7.0 million in legal settlement expenses. Full-year 2026 revenue guidance was narrowed to a range of $850 million to $860 million, with adjusted diluted earnings per share expected between $1.20 and $1.40.